PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28693255-1	2017	Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC).	Sunitinib	0-9	ret proto-oncogene	Homo sapiens	53-77	
28693255-1	2017	Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC).	Sunitinib	0-9	ret proto-oncogene	Homo sapiens	79-82	
28693255-1	2017	Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC).	Sunitinib	11-13	ret proto-oncogene	Homo sapiens	53-77	
28693255-1	2017	Sunitinib (SU) is a small molecule that inhibits the receptor tyrosine kinase (RTK) signaling pathway, and has been clinically used to treat advanced renal cell carcinoma (RCC).	Sunitinib	11-13	ret proto-oncogene	Homo sapiens	79-82